IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Provided By GlobeNewswire
Last update: Jun 24, 2024
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will participate in a fireside chat during the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024 at 2:30 p.m. ET.
0.1337
-0.01 (-9.78%)
Find more stocks in the Stock Screener
INAB Latest News and Analysis
7 days ago - ChartmillThese stocks are moving in today's after hours sessionLet's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
